Anton H. Amann Joins NexMed.LOS ANGELES--(BW HealthWire)--Oct. 1, 1997--Anton (Tony) H. Amann, Ph.D. has been named vice-president of NexMed Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB: NEXM). Amann will be responsible for NexMed's pharmaceutical manufacturing and off-patented drug development activities. Amann will also serve as a director and general manager of NexMed (Americas) Ltd., the company's wholly-owned subsidiary in Ontario, Canada. Amann has more than 27 years of experience in the pharmaceutical industry. From 1993 to 1997, he served as senior vice-president of Scientific Operations at Apotex USA Inc., and from 1990 to 1993, vice-president of Scientific Affairs at Chelsea Laboratories. In these positions, Amann held responsibilities for business development, manufacturing operations Manufacturing operations concern the operation of a facility, as opposed to maintenance, supply and distribution, health, and safety, emergency response, human resources, security, information technology and other infrastructural support organizations. , R&D, regulatory and quality assurance affairs. For the 20 years prior, Amann was in senior-level positions at various major pharmaceutical companies including Upjohn and Abott Laboratories. Dr. Joseph Mo, president & C.E.O., remarked, "Tony's scientific and technical experience in the pharmaceutical industry is invaluable to NexMed. He will play a pivotal role in our manufacturing operations as well as business development activities of off-patented products for international markets." Amann received a Ph.D. in Pharmaceutics from the University of Connecticut The University of Connecticut is the State of Connecticut's land-grant university. It was founded in 1881 and serves more than 27,000 students on its six campuses, including more than 9,000 graduate students in multiple programs. UConn's main campus is in Storrs, Connecticut. . Amann has published extensively, and is a recipient of numerous honors and distinctions. He is currently a director and secretary and treasurer of the National Association of Pharmaceutical Manufacturers, and also chairs its Technical Committee. Amann was appointed one of the two representatives for the U.S.A. generic industry to serve on the International Conference on Harmonization har·mo·nize v. har·mo·nized, har·mo·niz·ing, har·mo·niz·es v.tr. 1. To bring or come into agreement or harmony. See Synonyms at agree. 2. Music To provide harmony for (a melody). (ICH See Intel Hub Architecture. ). NexMed Inc. is an emerging international pharmaceutical company developing proprietary products based on its patented drug delivery technologies. Its stock is quoted on the OTC Bulletin Board OTC Bulletin Board An electronic quotation listing of the bid and asked prices of OTC stocks that do not meet the requirements to be listed on the NASDAQ stock-listing system. under the trading symbol Trading symbol See: Ticker symbol "NEXM." CONTACT: NexMed Inc., Los Angeles Vivian Liu, VP, 213/890-2951 email: nexmedla@aol.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion